Crohn's disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 42: Line 42:


===Microscopic Pathology===
===Microscopic Pathology===
On microscopic histo-pathological analysis of the affected colon may show [[mucosa]]l inflammation. Histo-pathological finding include
On microscopic analysis of the affected colon may show [[mucosa]]l inflammation. Histo-pathological finding include
*Transmural [[inflammation]] results in formation of lymphoid aggregates throughout the wall of the colon.  
*Transmural [[inflammation]]  
**This inflammation is characterized by focal infiltration of [[neutrophils]], a type of inflammatory cell, into the [[epithelium]]. 
*Lymphoid aggregates throughout the wall of the colon.
**This typically occurs in the area overlying [[lymphoid tissue|lymphoid]] aggregates. 
*Focal infiltration of [[neutrophils]] along with [[lymphocyte|mononuclear cells]], may infiltrate into the [[Crypts of Lieberkühn|crypts]] leading to inflammation (crypititis) or abscess (crypt abscess).
**These neutrophils, along with [[lymphocyte|mononuclear cells]], may infiltrate into the [[Crypts of Lieberkühn|crypts]] leading to inflammation (crypititis) or abscess (crypt abscess).  
*Non- caseating [[Granuloma]]s (aggregates of [[macrophage]] derivatives) known as giant cells, are found in 50% of cases and are most specific for Crohn's disease.
*[[Granuloma]]s, aggregates of [[macrophage]] derivatives known as giant cells, are found in 50% of cases and are most specific for Crohn's disease.
*Blunting of the intestinal [[villus|villi]]
**The granulomas of Crohn's disease do not show "caseation," a cheese-like appearance on microscopic examination that is characteristic of granulomas associated with infections such as [[tuberculosis]].
*Atypical branching of the crypts
*Biopsies may also show chronic mucosal damage as evidenced by blunting of the intestinal [[villus|villi]], atypical branching of the crypts, and change in the tissue type ([[metaplasia]]).
*''Paneth cell metaplasia'' <ref name="Robbins">Crawford JM.  "The Gastrointestinal tract, Chapter 17".  In Cotran RS, Kumar V, Robbins SL. ''Robbins Pathologic Basis of Disease: 5th Edition''.  W.B. Saunders and Company, Philadelphia, 1994.</ref>
**One example of such metaplasia, ''Paneth cell metaplasia'', involves development of Paneth cells (typically found in the small intestine) in other parts of the gastrointestinal system.<ref name="Robbins">Crawford JM.  "The Gastrointestinal tract, Chapter 17".  In Cotran RS, Kumar V, Robbins SL. ''Robbins Pathologic Basis of Disease: 5th Edition''.  W.B. Saunders and Company, Philadelphia, 1994.</ref>


[[Image:Crohn's transmural path.jpg|thumb|center|120px|H and E section of [[colectomy]] showing transmural inflammation.]]
[[Image:Crohn's transmural path.jpg|thumb|center|120px|H and E section of [[colectomy]] showing transmural inflammation.]]

Revision as of 19:39, 20 December 2017

https://https://www.youtube.com/watch?v=thzOJV-CHRo%7C350}}

Crohn's disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Crohn's Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Crohn's disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Crohn's disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Crohn's disease pathophysiology

CDC on Crohn's disease pathophysiology

Crohn's disease pathophysiology in the news

Blogs on Crohn's disease pathophysiology

Directions to Hospitals Treating Crohn's disease

Risk calculators and risk factors for Crohn's disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Genetic and environmental factors play a key role in the pathogenesis of Crohn's disease. Mutations in the CARD15 gene (also known as the NOD2 gene) are associated with Crohn's disease and with susceptibility to certain phenotypes of disease location and activity. Environmental factors include autoimmune Disease and dysregulated Immune Response to Commensal Bacteria. Characteristic features of the pathology that point toward Crohn's disease are transmural pattern of inflammation and skip lesions. Under microscopy Granulomas are seen, which are aggregates of macrophage derivatives known as giant cells, are found in 50% of cases and are most specific for Crohn's disease.

Pathophysiology

Genetic and environmental factors play a key role in the pathogenesis of Crohn's disease.

Genetics

  • Mutations in the CARD15 gene (also known as the NOD2 gene) are associated with Crohn's disease and with susceptibility to certain phenotypes of disease location and activity.[1][2]
  • In earlier studies, only two genes were linked to Crohn's, but scientists now believe there are over eight genes that show genetics play a crucial role in the disease.
  • Abnormalities in the immune system have often been invoked as being causes of Crohn's disease.
  • It has been hypothesized that Crohn's disease involves augmentation of the Th1 of cytokine response in inflammation.[3]
  • The most recent gene to be implicated in Crohn's disease is ATG16L1, which may reduce the effectiveness of autophagy, and hinder the body's ability to attack invasive bacteria.[4]

Environmental factors

Environmental factors include:

Autoimmune disease

  • Inflammatory response directed toward a self-antigen is believed to be responsible for development of Crohn's disease.
  • Neutrophils are the main group of the cells that are targeted.
  • Antineutrophil antibodies activate complement factors and localize on the luminal surface of the epithelium resulting in the destruction of intestinal tissue.

Immune reponse

  • T-cell activation from chronic inflammation resulting in tissue injury is believed to the main reason in the pathogenesis of Crohn disease.
  • After T cell activation by antigen presentation, unrestrained responses of type 1 T helper (Th1) cells predominate in Crohn disease as a consequence of defective regulation.
  • Th1 cytokines such as interleukin (IL)-12 and TNF-α stimulate the inflammatory response.
  • Inflammatory cells recruited by these cytokines release nonspecific inflammatory substances, including arachidonic acid metabolites, proteases, platelet activating factor, and free radicals, which result in direct injury to the intestine.

Gross Pathology

Characteristic features of the pathology that are suggestive of Crohn's disease include:

  • Transmural pattern of inflammation, meaning that the inflammation may span the entire depth of the intestinal wall.
  • Grossly, ulceration is an outcome seen in highly active disease.
  • There is usually an abrupt transition between unaffected tissue and the ulcer.

Microscopic Pathology

On microscopic analysis of the affected colon may show mucosal inflammation. Histo-pathological finding include

  • Transmural inflammation
  • Lymphoid aggregates throughout the wall of the colon.
  • Focal infiltration of neutrophils along with mononuclear cells, may infiltrate into the crypts leading to inflammation (crypititis) or abscess (crypt abscess).
  • Non- caseating Granulomas (aggregates of macrophage derivatives) known as giant cells, are found in 50% of cases and are most specific for Crohn's disease.
  • Blunting of the intestinal villi
  • Atypical branching of the crypts
  • Paneth cell metaplasia [5]
H and E section of colectomy showing transmural inflammation.

References

  1. Cuthbert A, Fisher S, Mirza M; et al. (2002). "The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease". Gastroenterology. 122 (4): 867–74. PMID 11910337.
  2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):603-6.
  3. Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev. 2005 Aug;206:277-95. PMID 16048555
  4. Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfield JC, Lewis CM, Schreiber S, Mathew CG. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology. 2007 May;132(5):1665-71. PMID: 17484864.
  5. Crawford JM. "The Gastrointestinal tract, Chapter 17". In Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease: 5th Edition. W.B. Saunders and Company, Philadelphia, 1994.

Template:WH Template:WS